Status:
TERMINATED
Evaluation of Myocardial Improvement in Patients Supported by Ventricular Assist Device Under Optimal Pharmacological Therapy
Lead Sponsor:
University Hospital, Strasbourg, France
Collaborating Sponsors:
Service de Chirurgie Cardiaque
Institut de Physiologie, Strasbourg, France
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Cardiac function may improve in patients with end-stage heart failure who receive long-term support with ventricular assist devices (VAD). Reverse left ventricular remodeling may be sufficient in some...
Detailed Description
Evaluation of Myocardial Improvement (Reverse Left Ventricular Remodeling, Mitochondrial Respiratory Function) in Patients Supported by Ventricular Assist Device Under Optimal Pharmacological Therapy
Eligibility Criteria
Inclusion
- Patients with end-stage heart failure refractory to medical therapy and who fulfill criteria for VAD implantation as a bridge to heart transplantation
- Age \> 18
Exclusion
- Myocarditis
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00402376
Start Date
April 1 2007
Last Update
August 30 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Chirurgie Cardiovasculaire - Hôpital Civil
Strasbourg, France, 67091
2
Service de Physiologie Clinique - Hôpital Civil
Strasbourg, France, 67091